Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study
Laurent Bonello, Corinne Frère, Sylvie Cointe et al. · International Journal of Cardiology · 2015
Cited by 38 works. doi:10.1016/j.ijcard.2015.03.414
Authors
- Laurent Bonello
- Corinne Frère
- Sylvie Cointe
- Marc Laine
- Julien Mancini
- Franck Thuny
- François Kerbaul
- Gilles Lemesle
- Franck F. Paganelli
- Régis Guieu
- Françoise Dignat‐George
- Florence Sabatier
References
- Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
- Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
- Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
- Platelet Activation and Atherothrombosis
- The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
- Statin Therapy Accelerates Reendothelialization
- Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance
- Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events